Black Rock Inc. Capricor Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,628,550 shares of CAPR stock, worth $29.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,628,550
Previous 381,735
326.62%
Holding current value
$29.5 Million
Previous $2.59 Million
199.81%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CAPR
# of Institutions
92Shares Held
8.13MCall Options Held
1.78MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA1.58MShares$28.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA638KShares$11.5 Million0.0% of portfolio
-
State Street Corp Boston, MA512KShares$9.27 Million0.0% of portfolio
-
Superstring Capital Management LP New York, NY337KShares$6.1 Million4.49% of portfolio
-
Ikarian Capital, LLC Dallas, TX300KShares$5.43 Million0.8% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $440M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...